A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) Visit us: http://azothanalytics.com/report/healthcare-pharma/global-nuclear-medicine-market-analysis-by-product-type-diagnostic-therapeutic-by-diagnostic-nuclear-medicine-type-by-therapeutic-nuclear-medicine-type-by-indication-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28197

1. Global Nuclear Medicine Market: Analysis By Product Type
(Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By
Therapeutic Nuclear Medicine Type, By Indication, By Region, By
Country (2019 Edition): Opportunities and Forecast (2013-2023)
• By Diagnostic Nuclear Medicine Type - SPECT, PET
• By Therapeutics Nuclear Medicine Type - Alpha
Emitters, Beta Emitters, Brachytherapy
• By Indication - Cardiovascular Disorders, Neurological
disorders, Oncological disorders, Others
• By Region- North America, Europe, APAC and ROW
• By Country – U.S, Canada, U.K, Germany, Japan,
China, India, Brazil
January 2019

2. 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Global
Market (By Value)           
By Product,
By Value
Diagnostic           
Therapeutic           
By Diagnostic
Nuclear Medicine,
By Value
SPECT           
PET           
By Therapeutics
Nuclear Medicine,
By Value
Alpha Emitters           
Beta Emitters           
Brachytherapy           
By Indications, By
Value
Cardiovascular
Disorders           
Neurological
Disorders           
Oncological Disorders           
Others           
Historical Forecast
Scope of the Report – Nuclear Medicine Market
2

3. 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Regional
Market (By Value)           
By Product,
By Value
Diagnostic           
Therapeutic           
By Diagnostic
Nuclear Medicine,
By Value
SPECT           
PET           
By Therapeutics
Nuclear Medicine,
By Value
Alpha Emitters           
Beta Emitters           
Brachytherapy           
By Indications, By
Value
Cardiovascular
Disorders           
Neurological
Disorders           
Oncological Disorders           
Others           
Historical Forecast
Scope of the Report – Nuclear Medicine Market
3

4. Country
By Indication, By
Value
          
Cardiovascular
Disorders           
Neurological
Disorders           
Oncological Disorders           
Others           
Company Analysis
Curium, Advanced Accelerator Applications, Jubilant Life Sciences, Cardinal Health, 3B Pharmaceutical Bracco Imaging,
Eckert & Ziegler ,Lantheus Holding
Regional Analysis North America, Europe, APAC and ROW
Country Analysis U.S, Canada, Germany, France, China, India, Japan and Brazil
Historical Forecast
Scope of the Report – Nuclear Medicine Market
4

5. Table of Content
S.No Particulars Page
No.
1. Research Methodology 24
2. Executive Summary 25
3. Strategic Recommendation 26
3.1 Focus on Technological Advancements
27
3.2 APAC region to witness augmented growth in the forecast period.
28
4. Nuclear Medicine Market Overview 30
5. Global Nuclear Medicine : Growth and Forecast 37
5.1 By Value (2013-2017) 38
5.2 By Value (2018-2023) 39
6. Global Nuclear Medicine Market: By Indication 45
6.1 Global Nuclear Medicine Market-By Product Type: Breakdown(%) 52
6.1.1 Global Nuclear Medicine Market Size and Share, By Product Type, 2017
53
6.1.2 Global Nuclear Medicine Market Size and Share, By Product Type, 2023
54
6.2 Global Diagnostic Nuclear Medicine Market Overview 55
6.2.1 By Value (2013-2023) 55
5

6. Table of Content
S. No Particulars Page
No.
6.3 Global Therapeutic Nuclear Medicine Market Overview 58
6.3.1 By Value (2013-2023) 58
7 Global Nuclear Medicine Market: By Therapeutic Type 62
7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%) 63
7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017 63
7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023 63
7.2 Global Beta Emitters Nuclear Medicine Market Overview 65
7.2.1 By Value (2013-2023) 65
7.3 Global Alpha Emitters Nuclear Medicine Market Overview 66
7.3.1 By Value (2013-2023) 66
7.4 Global Brachytherapy Nuclear Medicine Market Overview 68
7.4.1 By Value (2013-2023)
68
6

7. Table of Content
S. No Particulars Page
No.
8 Global Nuclear Medicine Market :By Diagnostic Type
69
8.1 Global Nuclear Medicine Market :By Diagnostic Type: Breakdown(%)
70
8.1.1 Global Nuclear Medicine Market :By Diagnostic Type, 2017
70
8.1.2 Global Nuclear Medicine Market :By Diagnostic Type, 2023
71
8.2 Global SPECT Nuclear Medicine Market Overview
72
8.2.1 By Value (2013-2023)
73
8.3 Global PET Nuclear Medicine Market Overview
75
8.3.1 By Value (2013-2023)
76
9 Global Nuclear Medicine Market :By Indication
78
9.1 Global Nuclear Medicine Market :By Indication: Breakdown(%)
79
9.1.1 Global Nuclear Medicine Market :Indication, 2017
79
9.1.2 Global Nuclear Medicine Market :Indication, 2023
80
7

8. Table of Content
S. No Particulars Page
No.
9.2 Global Nuclear Medicine For Oncological Disorders Market
81
9.2.1 By Value (2013-2023)
81
9.3 Global Nuclear Medicine For Cardiovascular Disorders Market
84
9.3.1 By Value (2013-2023)
84
9.4 Global Nuclear Medicine For Neurological Disorders Market
86
9.4.1 By Value (2013-2023)
86
9.5 Global Nuclear Medicine For Other Disorders Market
87
9.5.1 By Value (2013-2023)
87
10. Global Nuclear Medicine Market: Regional Analysis
88
10.1 Global Nuclear Medicine Market, By Region: Breakdown (%)
89
10.1.1 Global Nuclear Medicine Market Size, By Region, 2017 (%)
89
10.1.2 Global Nuclear Medicine Market Size, By Region, 2023 (%)
90
8

9. Table of Content
S. No Particulars Page
No.
10.2 North America Nuclear Medicine Market: An Analysis
91
10.2.1 By Value (2013-2017)
92
10.2.2 By Value (2018-2023)
94
10.3 North America Nuclear Medicine Market: Segment Analysis
95
10.3.1 North America Nuclear Medicine Market: By Product Type , By Value(2013-2023)
96
10.3.2 North America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023)
97
10.3.3 North America Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023)
98
10.3.4 North America Nuclear Medicine Market: By Indication, By Value (2013-2023)
99
10.4 North America Nuclear Medicine Market: Country Analysis (U.S. and Canada)
105
10.4.1 U.S. Nuclear Medicine Market, By Value (2013-2023)
106
10.4.1.1 U.S. Nuclear Medicine Market, By Indication, By Value (2013-2023)
108
9

10. Table of Content
S. No Particulars Page
No.
10.4.2 Canada Nuclear Medicine Market, By Value (2013-2023) 113
10.4.2.1 Canada Nuclear Medicine Market, By Indication, By Value (2013-2023) 114
10.5 Europe Nuclear Medicine Market: An Analysis 118
10.5.1 By Value (2013-2017) 119
10.5.2 By Value (2018-2023) 120
10.6 Europe Nuclear Medicine Market: Segment Analysis 123
10.6.1 Europe Nuclear Medicine Market: By Product Type , By Value(2013-2023) 124
10.6.2 Europe America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 125
10.6.3 Europe Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 126
10.6.4 Europe Nuclear Medicine Market: By Indication, By Value (2013-2023) 127
10.7 Europe Nuclear Medicine Market: Country Analysis (Germany, France., Rest of Europe) 131
10.7.1 Germany Nuclear Medicine Market, By Value (2013-2023) 134
10.7.1.1 Germany Nuclear Medicine Market, By Indication, By Value (2013-2023) 135
10.7.2 France Nuclear Medicine Market, By Value (2013-2023) 140
10.7.2.1 France Nuclear Medicine Market, By Indication, By Value (2013-2023)
141
10

11. Table of Content
S. No Particulars Page No.
10.7.3 Rest of Europe Nuclear Medicine Market, By Value (2013-2023) 146
10.8 Asia Pacific Nuclear Medicine Market: An Analysis 147
10.8.1 By Value (2013-2017) 148
10.8.2 By Value (2018-2023) 149
10.9 Asia Pacific Nuclear Medicine Market: Segment Analysis 150
10.9.1 Asia Pacific Nuclear Medicine Market: By Product Type , By Value(2013-2023) 151
10.9.2 Asia Pacific America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 152
10.9.3 Asia Pacific Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 153
10.9.4 Asia Pacific Nuclear Medicine Market: By Indication, By Value (2013-2023) 154
10.10 Asia Pacific Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of Asia Pacific) 157
10.10.1 China Nuclear Medicine Market, By Value (2013-2023) 160
10.10.1.1 China Nuclear Medicine Market, By Indication, By Value (2013-2023) 163
10.10.2 Japan Nuclear Medicine Market, By Value (2013-2023) 168
10.10.2.1 Japan Nuclear Medicine Market, By Indication, By Value (2013-2023) 170
10.10.3 India Nuclear Medicine Market, By Value (2013-2023) 175
10.10.3.1 India Nuclear Medicine Market, By Indication, By Value (2013-2023) 177
10.10.4 Rest of Asia Pacific Nuclear Medicine Market, By Value (2013-2023) 180
11

12. Table of Content
S. No Particulars Page
No.
10.11 Rest of World Nuclear Medicine Market: An Analysis 181
10.11.1 By Value (2013-2017) 182
10.11.2 By Value (2018-2023) 183
10.12 Rest of World Nuclear Medicine Market: Segment Analysis 184
10.12.1 Rest of World Nuclear Medicine Market: By Product Type , By Value(2013-2023) 185
10.12.2 Rest of World Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 186
10.12.3 Rest of World Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 187
10.12.4 Rest of World Nuclear Medicine Market: By Indication, By Value (2013-2023) 188
10.13 Rest of World Nuclear Medicine Market: Country Analysis (Brazil & Others) 192
10.13.1 Brazil Nuclear Medicine Market, By Value (2013-2023) 195
10.13.1 Brazil Nuclear Medicine Market, By Indication, By Value (2013-2023) 196
10.13.2 Others Nuclear Medicine Market, By Value (2013-2023) 201
12

13. Table of Content
S. No Particulars Page
No.
11. Market Dynamics 202
11.1 Drivers 203
11.2 Challenges 208
12. Market Trends 212
13. Porter’s Five Forces Analysis –Nuclear Medicine Market 213
14. SWOT Analysis –Nuclear Medicine Market 215
15. Supply Chain Analysis Nuclear Medicine Market 217
16. Policy and Regulatory Landscape 219
17. Competitive Landscape 227
18. Company Profiling 229
18.1
Eckert & Ziegler
230
18.2 Advanced Accelerator Applications 232
18.3 Cardinal Health 234
13

14. Table of Content
S. No Particulars Page
No.
18.4 3B Pharmaceuticals 236
18.5 Jubilant Life Sciences 237
18.6 Curium 239
18.7 Lantheus Holdings 240
18.8 Bracco Imaging 242
14

15. List of Figures
Figure No. Figure Title Page No.
Figure 1: Nuclear Medicine Market Segmentation Flowchart 35
Figure 2: Nuclear Medicine Market Segmentation Flowchart 36
Figure 3: Global Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 38
Figure 4: Global Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million) 39
Figure 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total) 41
Figure 6: Projected global population aged 60 years & above In Billions) 41
Figure 7: Projected global population (In Billions) 41
Figure 8: Global Health Expenditure Per Capita, (2012-2016, USD Trillion) 42
Figure 9: Global Health Expenditure Per Capita, By Select Countries,(2016, USD) 42
Figure 10: Global Nuclear Medicine Market Size, By Product Type, 2017 (%) 53
Figure 11: Global Nuclear Medicine Market Size, By Product Type, 2023F (%) 54
Figure 12: Global Diagnostic Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 55
Figure 13: Global Diagnostic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 55
Figure 14: Global Therapeutic Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 58
Figure 15: Global Therapeutic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 58
Figure 16: Global Prevalence of Different Type of Cancer (2013-2017, Thousands) 60
Figure 17: Global Nuclear Medicine Market Size, By Therapeutic Type, 2017 (%) 63
Figure 18: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%) 64
Figure 19: Global Beta Emitters Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 65
Figure 20: Global Beta Emitters Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 65
15

16. List of Figures
Figure No. Figure Title Page No.
Figure 21: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 66
Figure 22: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 66
Figure 23: Global Brachytherapy Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 68
Figure 24: Global Brachytherapy Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 68
Figure 25: Global Nuclear Medicine Market Size, By Diagnostic Type, 2017 (%) 70
Figure 26: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%) 71
Figure 27: Global SPECT Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 73
Figure 28: Global SPECT Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 73
Figure 29: Global PET Nuclear Medicine Market Size, By Value, 2013-2017(USD Million) 76
Figure 30: Global PET Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 76
Figure 31: Global Nuclear Medicine Market Size, By Indication, 2017 (%) 79
Figure 32: Global Nuclear Medicine Market Size, By Indication, 2023 (%) 80
Figure 33: Global Nuclear Medicine For Oncological Disorders Market Size, By Value,2013-2017(USD Million) 81
Figure 34: Global Nuclear Medicine For Oncological Disorders Market Size, By Value,2018E-2023F (USD Million) 81
Figure 35: Prevalence of Cancer Per 100,000 in different Countries in 2018 ( In Thousands) 82
Figure 36: Global Prevalence of Different Type of Cancer in year 2016 & 2017 ( In Thousands) 83
Figure 37: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2013-2017(USD Million) 84
Figure 38: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million) 84
Figure 39: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million) 85
Figure 40: Global Prevalence of Cardiovascular Disease (2012-2016 , Million) 85
16

17. List of Figures
Figure No. Figure Title Page No.
Figure 41: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2013-2017(USD Million) 86
Figure 42: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2018E-2023F (USD Million) 86
Figure 43: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million) 87
Figure 44: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million) 87
Figure 45: Global Nuclear Medicine Market Size, By Region, 2017 (%) 89
Figure 46: Global Nuclear Medicine Market Size, By Region, 2023F (%) 90
Figure 47: North America Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 92
Figure 48: North America Population above 65 year in Million (2015, 2030F, 2050F) 93
Figure 49: North America Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 94
Figure 50: North America Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 96
Figure 51: North America Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 97
Figure 52: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 98
Figure 53: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 99
Figure 54: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 101
Figure 55: Total Number of People With Cardiovascular Disorders in North America, By Type,2017 (In thousands) 101
Figure 56: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds) 102
Figure 57: North America Nuclear Medicine Market, Country Share, 2017 (% of Total) 104
Figure 58: North America Nuclear Medicine , Country Share, 2023F (% of Total) 104
Figure 59: United States Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 106
Figure 60: United States Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 106
17

18. List of Figures
Figure No. Figure Title Page No.
Figure 61: U.S. Per Capita Health Expenditure, 2012-2016 ( USD) 107
Figure 62: United States Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 108
Figure 63: New Estimated Cases of Cancer in United States, By Type 2018 110
Figure 64: New Estimated Cases of Cancer in United States (2014-2018) 110
Figure 65: Estimated Cases of Cardiovascular Disorders in United States (2013-2017)(In Thousands) 110
Figure 66: United States Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 111
Figure 67: Total Number of People With Cardiovascular Disorders in United States, By Type,2017 (In thousands) 111
Figure 68: Total Number of People With Cardiovascular Disorders in United States, By Type,2017 (In thousands) 113
Figure 69: Canada Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 113
Figure 70: Canada Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 114
Figure 71: Canada Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 116
Figure 72: Total Number of People With Cardiovascular Disorders in Canada, By Type,2017 (In thousands) 116
Figure 73: Prevalence of Different Type of Cancer in Canada in year 2016 & 2017 ( In Hundreds) 117
Figure 74: Cancer Fact Sheet of Canada, 2017 117
Figure 75: Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 119
Figure 76: Europe Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 120
Figure 77: Number of Magnetic Resonance Imaging (MRI) Scans By Using Imaging Equipment Number, 2016, Per
100,000 Inhabitants
121
Figure 78: Europe Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 124
Figure 79: Europe Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 125
Figure 80: Europe Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 126
18

19. List of Figures
Figure No. Figure Title Page No.
Figure 81: Europe Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 127
Figure 82: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Hundreds) 129
Figure 83: Western Europe Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 130
Figure 84: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2017 (In thousands) 130
Figure 85: Europe Nuclear Medicine Market, Country Share, 2017 (% of Total) 132
Figure 86: Europe Nuclear Medicine Market, Country Share, 2023 (% of Total) 132
Figure 87: Germany Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 134
Figure 88: Germany Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 134
Figure 89: Germany Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 135
Figure 90: Germany Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 137
Figure 91: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017 (In thousands) 137
Figure 92: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017 (In thousands) 138
Figure 93: France Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 140
Figure 94: France Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 140
Figure 95: France Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 141
Figure 96: France Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 143
Figure 97: Total Number of People With Cardiovascular Disorders in France, By Type,2017 (In thousands) 143
Figure 98: Prevalence of Different Type of Cancer in France in year 2016 & 2017 ( In Hundreds) 144
Figure 99: Rest of Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 146
Figure 100: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 146
19

20. List of Figures
Figure No. Figure Title Page No.
Figure 101: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 148
Figure 102: Asia Pacific Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 149
Figure 103: Asia Pacific Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 151
Figure 104: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 152
Figure 105: Asia Pacific Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 153
Figure 106: Asia Pacific Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 154
Figure 107: Asia Pacific Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 156
Figure 108: Total Number of People With Cardiovascular Disorders in Asia Pacific, By Type,2017 156
Figure 109: Asia Pacific Nuclear Medicine Market, Country Share, 2017 (% of Total) 158
Figure 110: Asia Pacific Nuclear Medicine, Country Share, 2023 (% of Total) 158
Figure 111: China Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 160
Figure 112: China Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 160
Figure 113: China Healthcare Expenditure (2012-2016, USD Billion) 161
Figure 114: China Population 65 Years & Above (% of Total), 2012-2016 161
Figure 115: China Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 163
Figure 116: China Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 165
Figure 117: Total Number of People With Cardiovascular Disorders in China, By Type,2017 (In thousands) 165
Figure 118: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds) 166
Figure 119: Japan Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 168
Figure 120: Japan Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 168
20

21. List of Figures
Figure No. Figure Title Page No.
Figure 121: Japan Per Capita Health Expenditure (2012-2016,USD) 169
Figure 122: Japan Population 65 Years & Above (% of Total), 2012-2016 169
Figure 123: Japan Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 170
Figure 124: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 172
Figure 125: Total Number of People With Cardiovascular Disorders in Japan, By Type,2017 (In thousands) 172
Figure 126: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds) 173
Figure 127: India Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million ) 175
Figure 128: India Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 175
Figure 129: India Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 177
Figure 130: Rest of Asia Pacific Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 180
Figure 131: Rest of Asia Pacific Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 180
Figure 132: Rest of World Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 182
Figure 133: Rest of World Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 183
Figure 134: Rest of World Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 185
Figure 135: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 186
Figure 136: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 187
Figure 137: Rest of World Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 188
Figure 138: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 190
Figure 139: Total Number of People With Cardiovascular Disorders in North Africa and Middle East , By Type,2017 (In
thousands)
190
Figure 140: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds) 191
21

22. List of Figures
Figure No. Figure Title Page No.
Figure 141: Rest of World Nuclear Medicine Market, Country Share, 2017 (% of Total) 193
Figure 142: Rest of World Nuclear Medicine , Country Share, 2023 (% of Total) 193
Figure 143: Brazil Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 195
Figure 144: Brazil Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million 195
Figure 145: Brazil Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 196
Figure 146: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 198
Figure 147: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017 (In thousands) 198
Figure 148: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds) 199
Figure 149: Others Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 201
Figure 150: Others Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 201
Figure 151: Eckert &Ziegler Sales, 2013-2017 (USD Million) 231
Figure 152: Eckert &Ziegler Sales, By Business Group, 2017 (%) 231
Figure 153: Advanced Accelerator Applications Sales, 2014-2016 (USD Million) 233
Figure 154: Advanced Accelerator Applications Sales, By Business Group, 2017 (%) 233
Figure 155: Advanced Accelerator Applications Sales, By Region, 2017 (%) 233
Figure 156: Cardinal Health Sales, 2013-2017 (USD Billion) 235
Figure 157: Cardinal Health Sales, By Business Group, 2017 (%) 235
Figure 158: Cardinal Health Sales, By Region, 2017 (%) 235
Figure 159: Jubilant Life Sciences Sales, 2015FY-2018FY (USD Million) 238
Figure 160: Jubilant Life Sciences Sales, By Business Group, 2017 (%) 238
22

23. List of Figures
Figure No. Figure Title Page No.
Figure 161: Jubilant Life Sciences Sales, By Region, 2017 (%) 238
Figure 162: Lantheus Holdings Revenue ,2016-2017 (USD Million) 241
Figure 163: Lantheus Holdings Revenue, By Product, 2017 (%) 241
Figure 164: Lantheus Holdings Revenue , By Region, 2017 (%) 241
Figure 165: Bracco Imaging Revenue , By Region, 2017 (%) 243
List of Table
Table A: List of Abbreviations 29
Table B: Recent Company Acquisitions ,Mergers & Partnership in Nuclear Medicine Market 47
Table C: Pipeline of Diagnostic Nuclear Medicine 48
Table D: Pipeline of Diagnostic Nuclear Medicine 49
Table E: Pipeline of Diagnostic Nuclear Medicine 50
Table F: Pipeline of Diagnostic Nuclear Medicine 51
Table G: Radionuclide Used for Diagnosis and Treatment 57
Table H: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies 61
Table I: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies 228
23

24. For our study on Global Nuclear Medicine market, we have conducted comprehensive secondary research
followed by an extensive primary research. In the process of secondary research, we have scrutinized
industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters,
Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various
industry experts across the value chain of medical device industry.
Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the
industry in the last five years, and confirming the findings through primary research. Annual reports of the
companies were scanned to further validate the market size and to estimate the size of various other end-
user sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product
mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the
industry. All the relevant data points/ statistics in the forecast period are validated through relevant and
reliable primary sources.
Report Focus: Global Nuclear Medicine Market
- By Product(Diagnostic, Therapeutic)
- By Diagnostic (SPECT, PET)
- By Therapeutic ( Alpha emitters, Beta Emitters, Brachytherapy)
-By Indication(Oncology, Neurology, cardiology, Others)
-By Region (North America, Europe, Asia Pacific and Rest of the World),
- By Country ( U.S., Canada, France, Germany, India, China, Japan and Brazil).
Research Methodology
24

25. Global Nuclear Medicine Market Overview
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
Xx
Xx
xx
2013 2014 2015 2016 2017
Figure 3: Global Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
CAGR 2013-2017
xx%
25

26. Global Nuclear Medicine Market Overview
xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates
CAGR 2018-2023
xx%
Figure 4: Global Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million)
26

27. Source: Azoth Analytics Estimates
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Global Diagnostic Nuclear Medicine Market
Figure 12: Global Diagnostic Nuclear Medicine Market
Size, By Value,2013-2017(USD Million)
Figure 13: Global Diagnostic Nuclear Medicine Market
Size, By Value,2018E-2023F (USD Million)
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
27

28. Source: Azoth Analytics Estimates
Global Therapeutic Nuclear Medicine Market
Figure 14: Global Therapeutic Nuclear Medicine Market
Size, By Value,2013-2017(USD Million)
Figure 15: Global Therapeutic Nuclear Medicine Market
Size, By Value,2018E-2023F (USD Million)
28
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

29. Global Nuclear Medicine Market- By Therapeutic Type
Figure 17: Global Nuclear Medicine Market Size, By
Therapeutic Type, 2017 (%)
xx
Alpha Emitters
Beta Emitters
Brachytherapy
Source: Azoth Analytics Estimates
Key Drivers
xx
xx
29

30. Global Nuclear Medicine Market- By Therapeutic Type
Figure 18: Global Nuclear Medicine Market Size, By Diagnostic
Type, 2023F (%)
xx
Source: Azoth Analytics Estimates
30
Alpha Emitters
Beta Emitters
Brachytherapy
Key Drivers
xx
xx

31. Source: Azoth Analytics Estimates
Global Beta Emitters Nuclear Medicine Market
Figure 19: Global Beta Emitters Nuclear Medicine
Market Size, By Value,2013-2017(USD Million)
Figure 20: Global Beta Emitters Nuclear Medicine Market
Size, By Value,2018E-2023F (USD Million)
31
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

32. • .
Source: Azoth Analytics Estimates
Global Alpha Emitters Nuclear Medicine Market
Figure 21: Global Alpha Emitter Nuclear Medicine
Market Size, By Value,2013-2017(USD Million)
Figure 22: Global Alpha Emitter Nuclear Medicine Market
Size, By Value,2018E-2023F (USD Million)
32
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

33. Figure 23: Global Brachytherapy Nuclear Medicine
Market Size, By Value,2013-2017(USD Million)
• .
Source: Azoth Analytics Estimates
Global Brachytherapy Nuclear Medicine Devices Market
Figure 24: Global Brachytherapy Nuclear Medicine Market
Size, By Value,2018E-2023F (USD Million)
33
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

34. Figure 27: Global SPECT Nuclear Medicine Market Size,
By Value,2013-2017(USD Million)
Source: Azoth Analytics Estimates
Global SPECT Nuclear Medicine Market
Figure 28: Global SPECT Nuclear Medicine Market Size,
By Value,2018E-2023F (USD Million)
34
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

35. Figure 29: Global PET Nuclear Medicine Market Size, By
Value, 2013-2017(USD Million)
• .
Source: Azoth Analytics Estimates
Global PET Nuclear Medicine Market
Figure 30: Global PET Nuclear Medicine Market Size, By
Value, 2018E-2023F (USD Million)
35
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

36. Global Nuclear Medicine Market- By Indication
Figure 31: Global Nuclear Medicine Market Size, By
Indication, 2017 (%)
xx
Oncological Disorder
Cardiovascular
Disorder
Neurological Disorder
Others
Source: Azoth Analytics Estimates
Key Drivers
xx
xx
36

37. Global Nuclear Medicine Market- By Indication
Figure 32: Global Nuclear Medicine Market Size, By
Indication, 2023 (%)
xx
Source: Azoth Analytics Estimates
37
Oncological Disorder
Cardiovascular
Disorder
Neurological Disorder
Others
Key Drivers
xx
xx

38. • .
Source: Azoth Analytics Estimates
Global Nuclear Medicine For Oncological Disorders Market
Figure 33: Global Nuclear Medicine For Oncological
Disorders Market Size, By Value,2013-2017(USD Million)
Figure 34: Global Nuclear Medicine For Oncological
Disorders Market Size, By Value,2018E-2023F (USD Million)
38
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

39. Figure 37: Global Nuclear Medicine For Cardiovascular
Disorders Market Size, By Value, 2013-2017(USD Million)
• .
Global Nuclear Medicine For Cardiovascular Disorders Market
Figure 38: Global Nuclear Medicine For Cardiovascular
Disorders Market Size, By Value, 2018E-2023F (USD Million)
Source: Azoth Analytics Estimates
39
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

40. 40
Global Nuclear Medicine For Cardiovascular Disorders Market
Cardiomyopathy And
Myocarditis
Rheumatic Heart Disease
Ischemic Heart Disease
Stroke
Hypertensive Heart Disease
Atrial Fibrillation and Flutter
Peripheral Artery Disease
Endocarditis
Others
Figure 39: Cardiovascular Disease Prevalence, By Type ,2016
Source: IHME
40

41. • .
Source: Azoth Analytics Estimates
Global Nuclear Medicine For Neurological Disorders Market
Figure 41: Global Nuclear Medicine For Neurological
Disorders Market Size, By Value,2013-2017(USD Million)
Figure 42: Global Nuclear Medicine For Neurological
Disorders Market Size, By Value,2018E-2023F (USD Million)
41
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

42. Figure 43: Global Nuclear Medicine For Others Disorders
Market Size, By Value,2013-2017(USD Million)
• .
Source: Azoth Analytics Estimates
Global Nuclear Medicine For Other Disorders Market
Figure 44: Global Nuclear Medicine For Others Disorders
Market Size, By Value,2018E-2023F (USD Million)
42
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

43. North America Nuclear Medicine Market Overview
Source: Azoth Analytics Estimates
Figure 47: North America Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Increasing prevalence of various chronic disorders has been backing the growth of market.
43
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2013 2014 2015 2016 2017
CAGR 2013-2017
xx%

44. Source: Azoth Analytics Estimates
Figure 49: North America Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
Surging penetration of government health schemes coupled with increasing number of nuclear
centres is foreseen to support the market for nuclear medicine.
North America Nuclear Medicine Market Overview
44
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx
2018 2019 2020 2021 2022 2023
CAGR 2018-2023
xx%

45. Source: Azoth Analytics Estimates
Figure 50: North America Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
CAGR 2013-2017
Diagnostic: xx%
Therapeutic: xx%
North America Nuclear Medicine Market, By Product
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Diagnostic 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Therapeutic 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2013-2017
Diagnostic: xx%
Therapeutic: xx%
Xx
Xx
Xx
Xx
Xx
Xx
45

46. Source: Azoth Analytics Estimates
Figure 51: North America Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
CAGR 2013-2017
SPECT: xx%
PET: xx%
North America Nuclear Medicine Market, By Diagnostic Type
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
SPECT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PET 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2013-2017
SPECT: xx%
PET: xx%
Xx
Xx
Xx
Xx
Xx
46

47. Source: Azoth Analytics Estimates
Figure 52: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)
CAGR 2013-2017
Alpha Emitters: xx%
Beta Emitters: xx%
Brachytherapy: xx%
North America Nuclear Medicine Market, By Therapeutic Type
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Alpha Emitters 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beta Emitters 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Brachytherapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2013-2017
Alpha Emitters: xx%
Beta Emitters: xx%
Brachytherapy: xx%
Xx
Xx
Xx
Xx
47

48. Source: Azoth Analytics Estimates
Figure 53: North America Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
CAGR 2013-2017
Oncological Disorders: xx%;
Cardiovascular Disorders: xx%;
Neurological Disorders: xx%
Others: xx%
North America Nuclear Medicine Market, By Indication
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Oncological Disorders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cardiovascular Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Neurological Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Oncological Disorders: xx%;
Cardiovascular Disorders: xx%;
Neurological Disorders: xx%
Others: xx%
48

49. • .
Source: Azoth Analytics Estimates
United States Nuclear Medicine Market Overview
Figure 59: United States Nuclear Medicine Market
Size, By Value, 2013-2017 (USD Million)
Figure 60: United States Nuclear Medicine Market
Size, By Value, 2018E-2023F (USD Million)
49
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx
Xx
Xx
Xx

50. Source: Azoth Analytics Estimates
Figure 62: United States Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
United States Nuclear Medicine Market – Analysis By Indication
50
CAGR 2013-2017
Oncological Disorders: xx%;
Cardiovascular Disorders: xx%;
Neurological Disorders: xx%
Others: xx%
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Oncological Disorders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cardiovascular Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Neurological Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CAGR 2018-2023
Oncological Disorders: xx%;
Cardiovascular Disorders: xx%;
Neurological Disorders: xx%
Others: xx%

51. About Azoth Analytics Pvt Ltd.
Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research
solutions and consulting services. An ISO 9001:2015 certified company, Azoth Analytics adheres to international quality management standard and has strong
commitment to a culture of continuous improvement. The business research and market analysis of Azoth Analytics helps organizations across different
industry verticals solve their business problems. Strategic market sizing and data dredging techniques include secondary research, and primary research
(interviews with management personnel and industry experts). Azoth Analytics provide syndicated and customized market research reports on different
verticals including pharmaceutical and healthcare, oil and gas and power, chemicals, automotive, technology, FMCG, food & beverages and media sectors.
Recent Azoth Analytics Reports
• Global Advanced Wound Care Market: Analysis By Type (Advanced Wound Dressings, Wound Therapy Devices, Wound Biologics), By
Application (Chronic Wounds, Acute Wounds), By End-User, By Region, By Country (2018 Edition): Opportunities and Forecasts (2018-
2023)
• Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition):
Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs,
Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)
• Global Transdermal Drug Delivery System Market: Analysis By Type (Patches, Gels), By Technique (Ionophoresis, Electroporation,
Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition): Trends, Opportunities and Forecast (2013-2023)
51